Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Ra... by Wenmin Chen MM, Jietao Lin MD, Ting Yang MM, Ze xin Zhang MM, Lanting Tao MD, Zhiwei Xiao MD, Hanrui Chen MM, Xiangjun Qi MM, Lingling Sun MD, Yang Cao MD, Lizhu Lin MD

Get full text